There was no evidence in either cell line for a role in resistance of increased expression of the MDR1/PgP membrane transporter protein, which has been reported as a frequent cause of resistance to PARP inhibition in other studies in breast and ovarian cancer cells [28,29]. The gene discussed is PGP; the disease is ovarian carcinoma.